A team of scientists from Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have identified a human monoclonal antibody able to protect pregnant mice and their developing fetuses from Zika virus infection. The research, published in November in Nature, was led by a Kerafast providing investigator from Vanderbilt University, co-senior
Viruses are continually finding ways to infect their hosts and evade their defenses. Through the evolution of the human race, we have been continually fighting viruses. A recent study published in the journal Nature Communications demonstrates that, in fact, this fight may have been going on much longer than originally thought. Ancient retroviral origins The
At Kerafast, our mission is to facilitate access to unique reagents developed by academic researchers. Together with our providing investigators, we get one-of-a-kind bioreagents into the hands of scientists worldwide who can use the materials to accelerate their own research. As we begin 2017, we took the opportunity to review how reagents in our catalog
Glioblastomas are tumors that develop from astrocytes and grow in the cerebral hemispheres of the brain. These tumors contain multiple cell types and are highly malignant. Glioblastomas rarely grow outside of the brain and most commonly lead to symptoms such as headache, nausea, vomiting and drowsiness. In some cases, memory, speech and vision can be
Zika, a virus transmitted primarily by Aedes mosquitoes, became a significant global health concern last year. The threat emerged in Brazil and quickly spread to other parts of the world, causing microencephaly and other birth defects in babies born to infected mothers, as well as rare neurological conditions in adults. Although Zika has faded from